M. Drolet

Most-cited papers

1. Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: The C‐SCOPE Study

   A. Litwin, M. Drolet, Chizoba U. Nwankwo, M. Torrens +6 more

   2019Journal of Viral Hepatitis67 citations Open access

   Semantic Scholar

   Save

2. Sexual Maturation and Fertility of Male Nigerian Dwarf Goat (Capra hircus) Clones Produced by Somatic Cell Nuclear Transfer

   M. Gauthier, J. Pierson, M. Drolet, B. Bhatia +2 more

   2001Cloning and Stem Cells26 citations

   Semantic Scholar

   Save

3. Perceptions and self-reported competency related to testing, management and treatment of hepatitis C virus infection among physicians prescribing opioid agonist treatment: The C-SCOPE study.

   J. Grebely, M. Drolet, Chizoba U. Nwankwo, M. Torrens +7 more

   2019The International journal on drug policy21 citations

   Semantic Scholar

   Save

4. Characterization of HCV-infected people who inject drugs (PWID) in the setting of clinical care in Canada (CAPICA): A retrospective study.

   B. Conway, J. Bruneau, C. Cooper, C. Steingart +12 more

   2020Canadian Liver Journal4 citations Open access

   Semantic Scholar

   Save

5. Decision analysis modelling of costs and outcomes following cefepime monotherapy in Canada.

   M. Halpern, Ruth E. Brown, M. Drolet, S. Sorensen +1 more

   1997The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses4 citations Open access

   Semantic Scholar

   Save

6. Real-world effectiveness of peginterferon α-2b plus ribavirin in a Canadian cohort of treatment-naïve chronic hepatitis C patients with genotypes 2 or 3: results of the PoWer and RediPEN studies

   P. Marotta, R. Bailey, M. Elkashab, J. Farley +7 more

   2016European Journal of Clinical Microbiology and Infectious Diseases3 citations Open access

   Semantic Scholar

   Save

7. Initiation and Dosing of Extended-Release Buprenorphine: A Narrative Review of Emerging Approaches for Patients Who Use Fentanyl

   Kenneth Lee, A. Mead, I. Ghauri, B. Hollett +2 more

   2025Substance Abuse and Rehabilitation1 citations Open access

   Semantic Scholar

   Save

8. Insight into people living with type 2 diabetes: a global survey of patients and physicians

   J. Ekoé, I. Iliopoulos, M. Drolet, N. Nasseri

   20091 citations

   Semantic Scholar

   Save

9. Impact of opioid agonist therapies on non-fatal and fatal overdose: treatment patterns among individuals with opioid use disorder in Ontario, Canada

   Kenneth Lee, Vincent Lam, Jenny Nicolle, M. Drolet +3 more

   2026Frontiers in Public Health0 citations Open access

   Semantic Scholar

   Save

10. 1011. Efficacy and Safety of Doravirine in Treatment-Naïve Adults ≥50 Years Old With HIV-1

    A. Mills, E. Martin, Chih-Chin Liu, M. Drolet +1 more

    2020Open Forum Infectious Diseases0 citations Open access

    Semantic Scholar

    Save

11. Physician Perceptions of and Competency in Hepatitis C Testing, Management, and Treatment Survey Questionnaire

    J. Grebely, M. Drolet, Chizoba U. Nwankwo, M. Torrens +7 more

    2020PsycTESTS Dataset0 citations

    Semantic Scholar

    Save

12. A27 CHARACTERIZATION OF HCV INFECTED PWID IN THE SETTING OF CLINICAL CARE IN CANADA (CAPICA): FINAL RESULTS

    J. Feld, B. Conway, J. Bruneau, C. Cooper +12 more

    20180 citations Open access

    Semantic Scholar

    Save

13. Real-world effectiveness of peginterferon α-2b plus ribavirin in a Canadian cohort of treatment-naïve chronic hepatitis C patients with genotypes 2 or 3: results of the PoWer and RediPEN studies

    P. Marotta, R. Bailey, M. Elkashab, J. Farley +7 more

    2016European Journal of Clinical Microbiology and Infectious Diseases0 citations Open access

    Semantic Scholar

    Save

14. UNM Digital Repository UNM Digital Repository

    Alain H. Litwin, M. Drolet, Chizoba U. Nwankwo, M. Torrens +8 more

    0 citations

    Semantic Scholar

    Save